The Biden administration announced the first of many coming federal investments in computer chip production, saying Monday that it would provide $35 million for BAE Systems to increase production at a New Hampshire factory making chips for military aircraft, including F-15 and F-35 jets.
This would be the initial allocation of incentives from last year’s bipartisan CHIPS and Science Act, which provides more than $52 billion to boost the development and manufacturing of s
At the United Nations’ COP28 climate summit in Dubai, surveillance cameras seem to be everywhere you turn. And that has some worried.
It’s unclear how the United Arab Emirates, an autocratic federation of seven sheikhdoms, uses the footage it gathers across its extensive network. However, the country already has deployed facial recognition at immigration gates at Dubai International Airport, the world’s busiest for international travel.
Surveillance ca
Greta Gerwig’s “Barbie” dominated the Golden Globe Awards nominations with nine nods for the blockbuster film, including best picture musical or comedy as well as acting nominations for Margot Robbie and Ryan Gosling and three of its original songs.
It was closely followed by its release date and meme companion “Oppenheimer,” which scored eight nominations, including best picture drama and for actors Cillian Murphy, Robert Downe
The creator economy is already estimated to be a $250 billion industry and is projected to hit $480 billion in just four more years, according to research from Goldman Sachs. However, only around 4% of global creators consider themselves professionals.
Part of the creator economy’s growing pains has been creators learning as they go. The resources for a more formalized approach to developing the craft and business acumen of being a creator is still nascent, which is exactly w
No matter where you turned this year, it seemed Elon Musk was there. The world’s richest man and CEO of multiple companies always seemed to be in the spotlight, even when it wasn’t especially flattering.
With a personality as large as Musk’s, it’s easy to focus on the individual. But as the year comes to a close, how have his companies performed? It’s a bit of a mixed bag—though some of his most ardent supporters and biggest detractors might
In a recent interview with Dua Lipa on her podcast, At Your Service, Apple CEO Tim Cook discussed something that he and Apple almost never address: the succession plan they have in place regarding the company’s leadership.
The mere thought of Tim Cook’s inevitable retirement is enough to send shivers down the spines of many of those on Wall Street. Cook is adored by both institutional and retail investors because he has seemingly achieved the impossible: sending Apple
The Bio-Block Spiral is a small, short wall, but it may be a bulwark against a giant threat: climate change. The curved, mud-colored structure is part of the current Chicago Architecture Biennial, entitled “Rehearsing the Future.” Unlike the artists’ installations filling the city’s downtown exhibit halls, the Bio-Block Spiral rises as a tight 15-foot-tall circle of concrete blocks outside the entrance to an office building that’s away from the action. Perha
Working her way up in tech, Nikitha Suryadevara saw many of her more senior colleagues investing their personal funds into new startups. “I would mention, ‘I saw that this company is doing XYZ’ or ‘That startup is doing this,’ and they’d say, ‘I invested in it,’ or ‘So and so asked me to write a check,’” says Suryadevara, a product manager who’s worked at Ritual, VMware, and Google. “I thought, That
2023 has been a busy year for Apple. While the company had its usual annual software launches, such as the iPhone’s iOS operating system and the Mac’s macOS operating system—along with annual hardware refreshes including the iPhone and Apple Watch—it has also had its first brand new product unveiling in years with the Apple Vision Pro.
As 2023 draws to a close, we look at the best moments Apple had during the year—and not all of them are product-re
On Friday, the U.S. Food and Drug Administration (FDA) approved a pair of gene therapies for the painful and potentially fatal blood disorder, sickle cell disease (SCD)–including the first-ever CRISPR gene-editing treatment. The gene-editing treatment from Vertex Pharmaceuticals and partner CRISPR Therapeutics is called Exa-cel and marketed as Casgevy. Regulators also gave the green light to Bluebird Bio’s lovo-cel (marketed as Lyfgenia), which uses a different type of technolog